通过CAR工程的淋巴细胞持久性是由FAS连接体/FAS自调节电路控制的
Fei Yi1, Tal Cohen1,2, Natalie Zimmerman1
1Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA.
bioRxiv : the preprint server for biology
|March 11, 2024
概括
CAR T和NK细胞的持久性受到FAS连接体 (FAS-L) 在T细胞,NK细胞和CAR细胞本身表达的限制. 阻断FAS-L可以改善CAR细胞的持久性,并增强抗瘤功效.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 癌症治疗 癌症治疗
背景情况:
- 化学抗原受体 (CAR) 工程的T和NK细胞对B细胞恶性瘤有希望,但面临有限的持久性.
- FAS连接体 (FAS-L) /FAS通路调节淋巴细胞稳态,但其在CAR细胞持久性中的作用尚不清楚.
研究的目的:
- 在癌症中识别表达FAS连接体 (FAS-L) 的细胞,并确定其对CAR T和NK细胞持久性的影响.
- 研究阻断FAS-L/FAS通路是否可以增强CAR细胞的持久性和抗瘤功效.
主要方法:
- 单细胞地图结构用于绘制不同癌症类型中FASLG基因表达的地图.
- 使用具有或没有主导负FAS受体 (ΔFAS) 的CAR T/NK细胞进行竞争性健身测定.
- FASLG淘汰实验和CAR介导瘤杀伤和抗瘤疗效的评估.
主要成果:
- 主要在内源性T细胞,NK细胞和CAR-T细胞中发现FASLG的表达,在瘤和树皮细胞中表达最小.
- 表达 ΔFAS 的 CAR T 和 NK 细胞表现出增强的持久性和组织丰富性,这被 FASLG 淘汰扭转.
- FASLG对于CAR介导的瘤杀死没有必要,但 ΔFAS 同表达改善了抗瘤疗效.
结论:
- 通过CAR设计的淋巴细胞持续性是由自调节的FAS-L/FAS电路调节的.
- 阻断FAS-L可以克服持久性限制,并提高CAR T和NK细胞疗法的疗效.
相关概念视频
B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
T Cell Activation and Clonal Selection
731
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
731
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
The Extrinsic Apoptotic Pathway
6.4K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.4K


